LifeMD

LifeMD

Yahoo Finance • 21 days ago

UPDATE - LifeMD Reports Second Quarter 2026 Results

UPDATE this press release has been updated to remove a duplicate table. Second quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted EBITDA loss of approximately $3.5 million, i... Full story

Yahoo Finance • last month

LifeMD to Report Second Quarter 2026 Financial Results on August 5

NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the clo... Full story

Yahoo Finance • 3 months ago

LifeMD to Participate in Upcoming Investor Conferences

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming investor conferences. LD Micro Invitatio... Full story

Yahoo Finance • 4 months ago

LifeMD (LFMD) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATE Wednesday, May 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Justin SchreiberChief Financial Officer — Atul Kavikar Need a quote from a Motley Fool analyst? Email pr@fool.com... Full story

Yahoo Finance • 5 months ago

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD, Inc. LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- LifeM... Full story

Yahoo Finance • 5 months ago

Novo launches $249 Wegovy subscription, undercutting Lilly as shares fall 30%

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) is stepping up its push to regain share in the obesity drug market, introducing a subscription-based pricing model that could improve access and pricing visibility for cash... Full story

Yahoo Finance • 5 months ago

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

LifeMD, Inc. Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD’s collaboration with Novo Nordisk NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of v... Full story

Yahoo Finance • 5 months ago

Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year

New subscription-based option helps eligible self-pay patients start and stay on Wegovy® with predictable pricing Available March 31, 2026, through Ro, WeightWatchers, LifeMD, with Hims & Hers, Sesame, and other telehealth providers coming... Full story

Yahoo Finance • 6 months ago

LifeMD Q4 Revenue Up 4%; Issues Q1, FY2026 Outlook; Stock Gains 6%

(RTTNews) - Shares of LifeMD Inc. (LFMD), a telehealth company, are up over 5% at $3.30 in the premarket today, following its fourth quarter and full-year 2025 financial results. In addition, the firm provided revenue guidance for the firs... Full story

Yahoo Finance • 8 months ago

LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend

* LifeMD, Inc. 8.875% CUM PFD A (LFMDP [https://seekingalpha.com/symbol/LFMDP]) declares $0.5547/share quarterly dividend [https://seekingalpha.com/pr/20349179-lifemd-declares-quarterly-dividend-on-series-a-cumulative-perpetual-preferred... Full story

Yahoo Finance • 8 months ago

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced that its Board of Directors has authorized a cash dividend to holders of... Full story

Yahoo Finance • 9 months ago

LifeMD outlines $192M-$193M 2025 revenue target amid margin shifts and expansion into women's and behavioral health

Earnings Call Insights: LifeMD, Inc. (LFMD) Q3 2025 MANAGEMENT VIEW * CEO Justin Schreiber reported significant progress on strategic initiatives, stating "Our RexMD business returned to growth adding approximately 10,000 net new subsc... Full story

Yahoo Finance • 9 months ago

LifeMD plunges following quarterly misses, updated guidance

[Close up image of wooden cubes with alphabet Q3 on office desk.] mohd izzuan * LifeMD (LFMD [https://seekingalpha.com/symbol/LFMD]) ia down ~16% in after-hours trading Monday after posting Q3 misses [https://seekingalpha.com/news/45231... Full story

Yahoo Finance • 9 months ago

LifeMD Reports Third Quarter 2025 Results

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million.Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% to $2.9 million.Paid off all outstanding... Full story

Yahoo Finance • 9 months ago

Here are the major earnings after the close Monday

Major earnings expected after the bell on Monday include: * Danaos Corporation (DAC [https://seekingalpha.com/symbol/DAC]) * Trip.com Group Limited (TCOM [https://seekingalpha.com/symbol/TCOM]) * Gladstone Capital Corporation (GLAD... Full story

Yahoo Finance • 9 months ago

Novo Nordisk cuts Wegovy, Ozempic direct-to-user prices to match Eli Lilly’s Zepbound

[Woman administering an injection at home for health and medical treatment] Milko Novo Nordisk (NVO [https://seekingalpha.com/symbol/NVO]) is cutting prices to challenge rival Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) in the o... Full story

Yahoo Finance • 9 months ago

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced a new, lower cash-pay price for GLP-1 medications, Wegovy® and Ozempic®, made poss... Full story

Yahoo Finance • 9 months ago

LifeMD Q3 2025 Earnings Preview

* LifeMD (LFMD [https://seekingalpha.com/symbol/LFMD]) is scheduled to announce Q3 earnings results on Monday, November 17th, after market close. The consensus EPS Estimate is $0.04 [https://seekingalpha.com/symbol/LFMD/earnings/estimate... Full story

Yahoo Finance • 10 months ago

LifeMD to Participate in the BTIG Digital Health Forum

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced its participation in the virtual BTIG Digital Health Forum on November 24, 2025. M... Full story

Yahoo Finance • 10 months ago

LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced that the Company has rescheduled its third quarter 2025 earnings release and confere... Full story